Management
Robert Thast
Interim CEO
Robert Thast brings over three decades of experience in public company management, capital markets, and executive leadership. He has served as CEO, senior executive, and director of several publicly traded companies, including En-Er-Tec International, Caldera Environmental, National Telecom Systems, Cap-Link Ventures, Floran Technologies, Capstream Ventures, New Carolin Gold Corp, and Capstream Ventures . Over the course of his career, he has worked with companies listed on the Canadian Securities Exchange (CSE), Toronto Stock Exchange (TSX), TSX Venture Exchange (TSXV), NASDAQ, and New York Stock Exchange (NYSE), and has helped lead companies through public listings, financings, and strategic transitions.
A skilled capital markets operator and team builder, Mr. Thast has personally raised over $100 million in equity funding for early- and growth-stage ventures. He began his career in executive recruitment, where he built a successful headhunting business known for identifying high-value talent and assembling leadership teams that attract strategic interest and influence. He continues to be recognized for his ability to source top-tier talent and retain support from industry stakeholders, scientific advisors, and capital partners.
As founding CEO of Izotropic Corporation, Mr. Thast has led the company from inception through its transition from R&D toward commercialization. He continues to oversee corporate development, financing strategy, and public market operations as Izotropic advances its flagship IzoView Breast CT Imaging System through U.S. FDA approval and toward global market entry. His leadership reflects a disciplined, investor-aligned approach focused on long-term value creation and advancing transformative technologies in healthcare.
Dr. John Boone
Ph.D., Principal Founder of Breast CT, Director
John M. Boone received his undergraduate degree in Biophysics from the University of California at Berkeley and went on to earn the Ph.D. at University of California Irvine in Medical Physics. He is now Distinguished Professor of Radiology at the University of California, Davis, and holds an appointment with the same title in Biomedical Engineering.
He was boarded certified by the American Board of Radiology in Diagnostic Medical Physics and has participated with colleagues in the clinical physics program at UC Davis for over 30 years. His 40 years of research has focused on a range of topics in medical physics. He has published extensively on Monte Carlo based radiation dosimetry in breast imaging and computed tomography, quantitative image performance metrics in imaging, and mathematical models for x-ray spectra with applications from mammography to orthovoltage therapy. He has designed, built and tested four dedicated breast CT scanners, with 467 women imaged in various clinical trials, and this work has shown that breast CT has excellent potential for screening and diagnostic imaging. Dr. Boone led projects in the American Association of Physicists in Medicine (AAPM) which developed the Size Specific Dose Estimate (SSDE) metric. The SSDE metric has been cited 1690 times and has been adopted in IEC 60601-44 by the International Electrotechnical Commission, so it will soon be deployed on all new CT scanners worldwide.
He is currently working with colleagues on the development multiple x-ray source arrays for breast tomosynthesis and whole body computed tomography. As an educator, Dr. Boone has graduated over 20 grad students at UC Davis. He is co-author of a 4-edition textbook widely used for teaching radiologists and medical physicists (Essential Physics of Medical Imaging). He has presented 200 invited lectures worldwide on six continents.
Dr. Boone served on the Research and Development Committee of the Radiological Society of North America and was 3rd vice president of the RSNA in 2016. He chaired the AAPM Science Council for 4 terms in the AAPM and served as AAPM president (2015) and chair of the board (2016). He was awarded the AAPM’s William D. Coolidge Gold Medal in 2019 and was awarded the Butterfly Award for the Image Gently organization that same year. In 2025, he was awarded the Award of Merit by the International Union for Science and Engineering Sciences in Medicine (IUSESM). He is currently Editor-in-Chief of the scientific journal Medical Physics.
Ralph Proceviat
CPA, CFO, Director
Ralph Proceviat, CPA, serves as Chief Financial Officer and Director of Izotropic Corporation, bringing over four decades of experience in finance, operations, and executive leadership across Canada, the U.S., and Europe. A Chartered Professional Accountant and PwC alumnus, Mr. Proceviat has held C-level positions including CEO, President, and CFO in a wide range of industries such as high tech, telecom, banking, software development, and entertainment. He has a proven track record of driving revenue growth, leading corporate restructurings, and raising tens of millions in debt and equity financings for both private and publicly traded companies. Ralph holds a Bachelor of Commerce in Management Information Systems from the University of British Columbia.
As founder of C-Suite-Consulting, Ralph is widely recognized as a trusted advisor to entrepreneurs, board members, and investors. His strategic expertise in deal structuring, financial engineering, and cross-border transactions has supported accelerated growth and value creation for companies at all stages of development. Known for his calm, pragmatic leadership style and ability to mentor executive teams through complex challenges, Ralph’s experience is especially well aligned with Izotropic’s mission to commercialize disruptive medical imaging technologies and scale into global markets.
Dr. Younes Achkire
Ph.D., Chief Operating Officer, Lead Engineer
Dr. Younes Achkire has over 20 years of engineering experience from startups to working with large teams in established organizations and brings a unique combination of business development, product positioning, engineering, medical device product development, manufacturing. As COO, he was responsible for the designing IzoView from the concept stage, through engineering phases, to the pre-commercial readiness stage, that includes sourcing the bill of materials and redundant supply of critical components.
Ali Sodagar
Legal Advisor, Director
Ali Sodagar serves as an independent Director on the Board of Izotropic Corporation, contributing a distinctive blend of scientific and legal expertise to the medical imaging sector. He holds a Bachelor's degree in Medical & Health Physics and a Master's degree in Medical Biophysics, with his MSc research specifically focused on the development and application of CT (Computed Tomography) systems for arterial and contrast-enhanced imaging. This robust academic foundation in diagnostic imaging technology provides him with a deep understanding of the industry, enabling him to offer informed strategic guidance on technological advancements and product development. In parallel, as the founder of Sodagar & Company Law Corporation, he specializes in business law, civil litigation, intellectual property, and international business transactions, areas that inform his contributions to the board's strategic discussions.
Beyond his board responsibilities and legal practice, Mr. Sodagar is an active participant and thought leader within the legal community. He has been a speaker at continuing legal education courses and international legal conferences. His firm actively practices in international business transactions, and he advises both domestic and international clients on corporate and commercial matters, reflecting a strong engagement with global legal and commercial landscapes.
Alexander Tokman
Director
Alexander Tokman is a growth-driven executive leader with over 25 years of global, cross-functional P&L leadership experience, specializing in building and scaling innovative technology businesses. He has a proven track record of driving breakthrough revenue growth, expanding international market presence, creating enterprise value, and leading successful business turnarounds across Fortune 100 corporations, publicly traded micro-cap companies, and private start-ups. His industry expertise spans medical devices, biotechnology, consumer electronics, IoT, AgTech, semiconductors, and artificial intelligence.
Alex has led multidisciplinary organizations ranging from 25 to over 1,500 employees and is skilled in managing strategic planning, product marketing and sales, business development, R&D, operations, investor relations, and M&A. Notable accomplishments include growing revenue from $30 million to over $550 million in under three years for a Fortune 100 medical device company, and restructuring a struggling public micro-cap technology company that achieved 300%+ revenue growth and increased market capitalization from $50 million to $500 million in the consumer electronics and IoT space. He also developed a multi-year roadmap for digital diagnostics applications for a globally recognized AI organization and closed multiple large-scale B2B deals exceeding $20 million with companies such as Sony, Microsoft, Pioneer, and Bosch.
In addition, Alex has built a globally recognized intellectual property portfolio, ranked Top 20 by IEEE and Ocean Tomo, comprising over 500 patents. He has raised more than $450 million from public markets and strategic private investors for four public and private companies and has led or participated in nine M&A transactions across the MedTech, Biotech, Consumer Electronics, and AgTech sectors. He currently serves on the boards of two publicly traded technology companies and two nonprofit organizations.
Dr. Andrew Hernandez
Ph.D., Head of Imaging Technology
Dr. Hernandez has a Ph.D. in Biomedical Engineering and currently holds an Assistant Professor position at the University of California, Davis, where his focus includes computer simulations and design of novel imaging modalities, assessment of model observer performance for clinically relevant tasks, and assessment of the diagnostic performance of x-ray imaging devices.
Dr. Hernandez has spent the last 12 years working on the design, development, and optimization of breast CT at the University of California, Davis, where he has worked under the mentorship of Dr. John M. Boone, Principal breast CT Founder and Company Director.
Jaclyn Thast
Operations Manager
Jaclyn Thast is a strategic professional with a strong foundation in business development, corporate communications, and investor engagement, particularly within regulated and innovation-driven industries. She has supported companies through key growth phases, contributing to regulatory planning, commercialization strategy, and capital markets positioning.
Jaclyn serves as the operations manager for the entire organization, where she oversees corporate workflows, manages external consultants, and coordinates internal processes to ensure alignment across teams. She plays a central role in project management, helping to drive execution on strategic initiatives and streamline day-to-day operations. In addition to her operational leadership, Jaclyn is an experienced writer specializing in corporate press releases and regulatory communications. She also manages accounting and bookkeeping, the coordination of financings and governance activities, and holds an Officer position as Corporate Secretary. Known for her ability to align teams, maintain structure, and execute with clarity, Jaclyn brings cross-functional expertise and disciplined oversight to both strategic and operational functions.